Infant Meningococcal Vaccination: Advisory Committee on Immunization Practices (ACIP) Recommendations and Rationale

Morbidity and Mortality Weekly Report

Volumn 62, Issue 3, 2013, Pages 52-54

  Rubin, Lorry ^a   Cohn, Amanda ^b   MacNeil, Jessica ^b   Messonnier, Nancy ^b  

^a Meningococcal Vaccines Work Group   (United States)

^b NATIONAL CENTER FOR IMMUNIZATION AND RESPIRATORY DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HAEMOPHILUS VACCINE; HIB MENCY TT VACCINE; HIB-MENCY-TT VACCINE; TETANUS TOXOID; VACCINE;

ADVISORY COMMITTEE; ARTICLE; DECISION MAKING; HAEMOPHILUS INFECTION; HAEMOPHILUS INFLUENZAE TYPE B; HUMAN; IMMUNIZATION; INFANT; MENINGOCOCCOSIS; PRACTICE GUIDELINE; RISK; STANDARD; UNITED STATES;

ADVISORY COMMITTEES; DECISION MAKING; HAEMOPHILUS INFECTIONS; HAEMOPHILUS INFLUENZAE TYPE B; HAEMOPHILUS VACCINES; HUMANS; IMMUNIZATION; INFANT; MENINGOCOCCAL INFECTIONS; PRACTICE GUIDELINES AS TOPIC; RISK; TETANUS TOXOID; UNITED STATES; VACCINES, CONJUGATE;

EID: 84873158228     PISSN: 01492195     EISSN: 1545861X     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. CDC. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR 2005;54(No. RR-7).
2. CDC. Licensure of a meningococcal conjugate vaccine for children aged 2 through 10 years and updated booster dose guidance for adolescents and other persons at increased risk for meningococcal disease-Advisory Committee on Immunization Practices (ACIP), 2011. MMWR 2011;60:1018-9.
3. Food and Drug Administration. Package insert for MenHibrix (meningococcal groups C and Y and Haemophilus b tetanus toxoid conjugate vaccine). Available at http://www.fda.gov/downloads/biologicsbloodvaccines/vaccines/approvedproducts/ucm308577.pdf.
4. Borrow R, Balmer P, Miller E. Meningococcal surrogates of protection-serum bactericidal antibody activity. Vaccine 2005;23:2222-7.
5. Bryant KA, Marshall GS, Marchant CD, et al. Immunogenicity and safety of H influenzae type b-N meningitidis C/Y conjugate vaccine in infants. Pediatrics 2011;127:e1375-85.
6. Marchant CD, Miller JM, Marshall GS, et al. Randomized trial to assess immunogenicity and safety of Haemophilus influenzae type b and Neisseria meningitidis serogroups C and Y-tetanus toxoid conjugate vaccine in infants. Pediatr Infect Dis J 2010;29:48-52.
7. Nolan T, Richmond P, Marshall H, et al. Immunogenicity and safety of an investigational combined Haemophilus influenzae type B-Neisseria meningitidis serogroups C and Y-tetanus toxoid conjugate vaccine. Pediatr Infect Dis J 2011;30:190-6.
8. CDC. CDC health information for international travel 2012. New York, NY: Oxford University Press; 2012. Available at http://wwwnc.cdc.gov/travel/yellowbook/2012/table-of-contents.htm.
9. Kaplan SL, Schutze GE, Leake JA, et al. Multicenter surveillance of invasive meningococcal infections in children. Pediatrics 2006;118:e979-84.
10. Cohn AC, MacNeil JR, Harrison LH, et al. Changes in Neisseria meningitidis disease epidemiology in the United States, 1998-2007: implications for prevention of meningococcal disease. Clin Infect Dis 2010;50:184-91.